BR112012016926A2 - composição probiótica de bifidobactéria de acordo com o estado do grupo sanguíneo secretor - Google Patents

composição probiótica de bifidobactéria de acordo com o estado do grupo sanguíneo secretor

Info

Publication number
BR112012016926A2
BR112012016926A2 BR112012016926A BR112012016926A BR112012016926A2 BR 112012016926 A2 BR112012016926 A2 BR 112012016926A2 BR 112012016926 A BR112012016926 A BR 112012016926A BR 112012016926 A BR112012016926 A BR 112012016926A BR 112012016926 A2 BR112012016926 A2 BR 112012016926A2
Authority
BR
Brazil
Prior art keywords
state
blood group
probiotic composition
bifidobacterium according
secretory
Prior art date
Application number
BR112012016926A
Other languages
English (en)
Portuguese (pt)
Inventor
Mäkivuokko Harri
Mätö Jaana
Wacklin Pirjo
Original Assignee
Suomen Punainen Risti Veripalvelu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suomen Punainen Risti Veripalvelu filed Critical Suomen Punainen Risti Veripalvelu
Publication of BR112012016926A2 publication Critical patent/BR112012016926A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BR112012016926A 2009-12-28 2010-12-28 composição probiótica de bifidobactéria de acordo com o estado do grupo sanguíneo secretor BR112012016926A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20096400A FI20096400A0 (fi) 2009-12-28 2009-12-28 Veriryhmästatuksen käyttö I
US12/843,404 US20110158950A1 (en) 2009-12-28 2010-07-26 Use of blood group status i
PCT/FI2010/051093 WO2011080395A2 (en) 2009-12-28 2010-12-28 Use of blood group status i

Publications (1)

Publication Number Publication Date
BR112012016926A2 true BR112012016926A2 (pt) 2019-09-24

Family

ID=41462858

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012016926A BR112012016926A2 (pt) 2009-12-28 2010-12-28 composição probiótica de bifidobactéria de acordo com o estado do grupo sanguíneo secretor

Country Status (7)

Country Link
US (1) US20110158950A1 (enExample)
EP (1) EP2519255A2 (enExample)
CN (1) CN102781466B (enExample)
BR (1) BR112012016926A2 (enExample)
FI (1) FI20096400A0 (enExample)
IN (1) IN2012DN06393A (enExample)
WO (1) WO2011080395A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012013861A2 (en) * 2010-07-26 2012-02-02 Suomen Punainen Risti Veripalvelu Use of blood group status iii
US20150265661A1 (en) * 2012-04-13 2015-09-24 Trustees Of Boston College Prebiotic effect of sialyllactose
CN105385762A (zh) * 2015-12-10 2016-03-09 扬州市扬大康源乳业有限公司 一种快速鉴定双歧杆菌的方法
EP3419630A4 (en) 2016-02-24 2019-11-06 Glycom A/S SYNTHETIC COMPOSITION FOR MICROBIOTA MODULATION

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826928A1 (de) * 1998-06-17 1999-12-23 Novartis Consumer Health Gmbh Arzneimittel, lebensfähige anaerobe Bakterien enthaltend, die die Sulfatreduktion sulfatreduzierender Bakterien hemmen
US6613549B2 (en) * 2000-02-10 2003-09-02 Urex Biotech, Inc. Probiotic therapy for newborns
AU2002329043A1 (en) * 2001-07-30 2003-02-24 Claudio De Simone Treatment of radiation-induced diarrhea with probiotics
JP4709838B2 (ja) * 2004-08-05 2011-06-29 アニドラル エス．アール．エル． 葉酸産生ビフィドバクテリウム菌株、製剤およびこれらの用途
ITMI20042189A1 (it) * 2004-11-16 2005-02-16 Anidral Srl Composizione a base di batteri probiotici e suo uso nella prevenzione e-o nel trattamento di patologie e-o infezioni respiratorie e nel miglioramento della funzionalita' intestinale
ES2381211T3 (es) * 2006-02-15 2012-05-24 Nestec S.A. Uso del Bifidobacterium longum para prevenir y tratar inflamaciones
WO2009033011A1 (en) * 2007-09-07 2009-03-12 Children's Hospital Medical Center Use of secretor, lewis and sialyl antigen levels as predictors for disease
US20090098088A1 (en) * 2007-10-10 2009-04-16 The Procter & Gamble Company Methods And Kits For The Treatment Of Diverticular Conditions

Also Published As

Publication number Publication date
CN102781466A (zh) 2012-11-14
WO2011080395A2 (en) 2011-07-07
EP2519255A2 (en) 2012-11-07
US20110158950A1 (en) 2011-06-30
WO2011080395A3 (en) 2011-09-15
FI20096400A0 (fi) 2009-12-28
CN102781466B (zh) 2015-11-25
IN2012DN06393A (enExample) 2015-10-02

Similar Documents

Publication Publication Date Title
IL265327A (en) xten duo preparations and methods for their production
IL265707A (en) Pharmaceutical preparations containing human antibodies to pcsk9
PL2831287T3 (pl) Kompozycja na bazie szczepów bakterii bifidobacterium longum zdolnych do wspomagania przedłużania życia
HRP20180559T1 (hr) Probiotičke terapije za autizam
CL2013001134A1 (es) Composicion de yogurt congelado que comprende microorganismos probioticos no replicantes .
ZA201207377B (en) Composition comprising probiotic bacteria for use in the treatment of immune disorders
BRPI0810087A2 (pt) Cepas de bifidobacterium probióticas
DK2385837T3 (da) Sammensætninger omfattende probiotiske og præbiotiske bestanddele og mineralsalte, med lactoferrin
ME03475B (me) Antiparazitske kompozicije dihidroazola
CL2014002903A1 (es) Composición geopolimérica de aluminosilicato; método de preparacion y sus usos.
DK2318513T3 (da) Ny probiotisk bifidobacterium longum
FI20095836L (fi) Probioottinen valmiste koirien maha- ja suolistohäiriöiden ennaltaehkäisyyn tai hoitoon
PL2734049T3 (pl) Kompozycje probiotyczne i sposoby
ZA201204459B (en) Formulations of antibody
PT2493487T (pt) Composição para induzir uma tolerância imunitária específica
FI20095529L (fi) Probioottien uusi käyttö
BR112012001812A2 (pt) uso de bactérias de ácido lático ou bifidobacterium ou uma mistura dessas
BRPI0917958A2 (pt) Produção de microesferas compreendendo compostos probióticos
CL2013001314A1 (es) Composicion de yogur de consistencia espesa que comprende microorganismos probióticos no replicantes.
CO6940377A2 (es) Formulaciones de liofilizadas de fgf-18
EP2552447A4 (en) STABLE PHARMACEUTICAL COMPOSITION OF IMATINIB
EP2494966A4 (en) STABLE COMPOSITION OF RASAGILINE
EP2690972A4 (en) GLUCOSYLSTEVIA COMPOSITION
BR112012016926A2 (pt) composição probiótica de bifidobactéria de acordo com o estado do grupo sanguíneo secretor
EP2490724A4 (en) COMPOSITIONS FOR IMPROVING THE POTENTIAL OF MIGRATION OF STEM CELLS

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B25A Requested transfer of rights approved

Owner name: DUPONT NUTRITION BIOSCIENCES APS. (DK)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.